C.difficile
Nov 07, 2016
Merck’s Antibody for Clostridium Difficile
Merck provided substantial evidence of safety and effectiveness for the approval of bezlotoxumab in June 2016 to the FDA, and the administration’s Antimicrobial Drugs Advisory Committee voted 10 to 5 with 1 abstention to recommend its approval. In October 2016, bezlotoxumab commercialized as Zinplava, got approved b...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
